Annual EBITDA
-$11.28 M
+$6.01 M+34.77%
December 31, 2023
Summary
- As of February 7, 2025, ALLR annual EBITDA is -$11.28 million, with the most recent change of +$6.01 million (+34.77%) on December 31, 2023.
- During the last 3 years, ALLR annual EBITDA has fallen by -$5.23 million (-86.40%).
- ALLR annual EBITDA is now -86.40% below its all-time high of -$6.05 million, reached on December 31, 2020.
Performance
ALLR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$11.91 M
-$10.71 M-891.01%
September 1, 2024
Summary
- As of February 7, 2025, ALLR quarterly EBITDA is -$11.91 million, with the most recent change of -$10.71 million (-891.01%) on September 1, 2024.
- Over the past year, ALLR quarterly EBITDA has dropped by -$8.17 million (-218.25%).
- ALLR quarterly EBITDA is now -891.01% below its all-time high of -$1.20 million, reached on June 1, 2024.
Performance
ALLR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$18.26 M
-$7.51 M-69.85%
September 1, 2024
Summary
- As of February 7, 2025, ALLR TTM EBITDA is -$18.26 million, with the most recent change of -$7.51 million (-69.85%) on September 1, 2024.
- Over the past year, ALLR TTM EBITDA has dropped by -$6.48 million (-55.04%).
- ALLR TTM EBITDA is now -1182.09% below its all-time high of -$1.42 million, reached on September 30, 2020.
Performance
ALLR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ALLR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.8% | -218.3% | -55.0% |
| 3 y3 years | -86.4% | -218.3% | -55.0% |
| 5 y5 years | +27.7% | -218.3% | -55.0% |
ALLR EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +56.2% | -891.0% | +27.2% | -69.8% | +40.4% |
| 5 y | 5-year | -86.4% | +56.2% | -891.0% | +27.2% | -1182.1% | +40.4% |
| alltime | all time | -86.4% | +56.2% | -891.0% | +27.2% | -1182.1% | +40.4% |
Allarity Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$11.91 M(+891.0%) | -$18.26 M(+69.8%) |
| Jun 2024 | - | -$1.20 M(-67.9%) | -$10.75 M(-8.7%) |
| Mar 2024 | - | -$3.74 M(+167.4%) | -$11.78 M(+4.4%) |
| Dec 2023 | -$11.28 M(-34.8%) | -$1.40 M(-68.2%) | -$11.28 M(-12.6%) |
| Sep 2023 | - | -$4.40 M(+97.6%) | -$12.91 M(-4.3%) |
| Jun 2023 | - | -$2.23 M(-31.4%) | -$13.49 M(-17.3%) |
| Mar 2023 | - | -$3.25 M(+7.5%) | -$16.30 M(-5.8%) |
| Dec 2022 | -$17.30 M | -$3.02 M(-39.4%) | -$17.30 M(-43.5%) |
| Sep 2022 | - | -$4.99 M(-1.1%) | -$30.64 M(+13.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$5.04 M(+18.8%) | -$26.90 M(-0.6%) |
| Mar 2022 | - | -$4.25 M(-74.1%) | -$27.06 M(+5.2%) |
| Dec 2021 | -$25.77 M(+325.7%) | -$16.36 M(+1207.0%) | -$25.73 M(+137.2%) |
| Sep 2021 | - | -$1.25 M(-75.9%) | -$10.85 M(-1.6%) |
| Jun 2021 | - | -$5.20 M(+78.3%) | -$11.02 M(+89.4%) |
| Mar 2021 | - | -$2.92 M(+97.4%) | -$5.82 M(+100.5%) |
| Dec 2020 | -$6.05 M(-61.2%) | -$1.48 M(+3.8%) | -$2.90 M(+103.8%) |
| Sep 2020 | - | -$1.42 M | -$1.42 M |
| Dec 2019 | -$15.61 M | - | - |
FAQ
- What is Allarity Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Allarity Therapeutics?
- What is Allarity Therapeutics annual EBITDA year-on-year change?
- What is Allarity Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Allarity Therapeutics?
- What is Allarity Therapeutics quarterly EBITDA year-on-year change?
- What is Allarity Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Allarity Therapeutics?
- What is Allarity Therapeutics TTM EBITDA year-on-year change?
What is Allarity Therapeutics annual EBITDA?
The current annual EBITDA of ALLR is -$11.28 M
What is the all time high annual EBITDA for Allarity Therapeutics?
Allarity Therapeutics all-time high annual EBITDA is -$6.05 M
What is Allarity Therapeutics annual EBITDA year-on-year change?
Over the past year, ALLR annual EBITDA has changed by +$6.01 M (+34.77%)
What is Allarity Therapeutics quarterly EBITDA?
The current quarterly EBITDA of ALLR is -$11.91 M
What is the all time high quarterly EBITDA for Allarity Therapeutics?
Allarity Therapeutics all-time high quarterly EBITDA is -$1.20 M
What is Allarity Therapeutics quarterly EBITDA year-on-year change?
Over the past year, ALLR quarterly EBITDA has changed by -$8.17 M (-218.25%)
What is Allarity Therapeutics TTM EBITDA?
The current TTM EBITDA of ALLR is -$18.26 M
What is the all time high TTM EBITDA for Allarity Therapeutics?
Allarity Therapeutics all-time high TTM EBITDA is -$1.42 M
What is Allarity Therapeutics TTM EBITDA year-on-year change?
Over the past year, ALLR TTM EBITDA has changed by -$6.48 M (-55.04%)